Targeting MDR in Breast and Lung Cancer: Discriminating Its Potential Importance From the Failure of Drug Resistance Reversal Studies
Drug Resistance Updates - United States
doi 10.1016/j.drup.2012.02.002
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2012
Authors
Publisher
Elsevier BV